Clinical Trial Update: Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Intensive Care (COMPAXE-HNF) [NA]

View source ↗

Summary

A pediatric clinical trial (COMPAXE-HNF) compares methods for measuring Anti-Xa activity in children receiving unfractionated heparin in a cardiac intensive car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Centre Hospitalier Universitaire de la Réunion | Conditions: Congenital Heart Disease, Unfractionated Heparin | NA | Status: NOT_YET_RECRUITING